Detalles de la búsqueda
1.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 258-267, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571770
2.
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort.
Oncologist
; 25(9): e1292-e1302, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324927
3.
Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis.
Reprod Biol Endocrinol
; 21(1): 68, 2023 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37496043
4.
Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA.
Future Oncol
; 13(19): 1699-1710, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28605939
5.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(1): 59-68, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331154
6.
Risk assessment of drug-drug interaction potential for bintrafusp alfa with cytochrome P4503A4 substrates: A totality of evidence approach.
Clin Transl Sci
; 15(12): 2838-2843, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152313
7.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort.
Target Oncol
; 16(4): 435-446, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34009501
8.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFß and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia.
Target Oncol
; 16(4): 447-459, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33840050
9.
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-ß and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma.
Neurooncol Adv
; 3(1): vdab058, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34056607
10.
Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFß and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer.
Clin Cancer Res
; 26(13): 3202-3210, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299818
11.
Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay.
J Thorac Oncol
; 15(8): 1306-1316, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353599
12.
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort.
J Immunother Cancer
; 8(2)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641320
13.
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in patients with pretreated biliary tract cancer.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32461347
14.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial.
J Thorac Oncol
; 15(7): 1210-1222, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32173464
15.
Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510).
J Gynecol Obstet Hum Reprod
; 52(8): 102640, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549879
16.
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFß, in Advanced Solid Tumors.
Clin Cancer Res
; 24(6): 1287-1295, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29298798
17.
Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer.
Lung Cancer
; 105: 23-30, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28236981
18.
Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe.
Oncotarget
; 8(45): 79731-79741, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108353
Resultados
1 -
18
de 18
1
Próxima >
>>